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Objectives The study sought to determine if left internal thoracic artery (LITA) grafting of the left anterior descending (LAD)
at reoperative coronary artery bypass grafting (CABG) improves patient outcomes.
Background LITA grafting to the LAD is the gold standard for primary CABG, but its value for reoperative CABG is unknown.
Methods From January 1985 to January 2007, reoperative CABG was performed in 3,473 patients who did not receive a
LITA during their primary CABG and whose anterior myocardium (LAD) was at risk at reoperation: 2,389 had
LITA grafting and 1,084 saphenous vein (SV) grafting to the LAD. Propensity matching (908 matched pairs) was
used for balanced comparison of outcomes. Follow-up was continued to 20 years post-operatively, with a mean
follow-up of 11  8.2 years.
Results Unadjusted hospital mortality was 2.2% and 6.5% in the LITA and SV groups, respectively (p  0.001), but 3.1%
and 5.6% in propensity-matched groups (p  0.008). Unadjusted survival at 1, 5, 10, 15, and 20 years was 94%,
82%, 64%, 46%, and 32% for the LITA group, but 88%, 73%, 50%, 32%, and 18% for the SV group (p .0001),
respectively. For propensity-matched groups, both early (p  0.01) and late survival was greater (p  0.005) in
the LITA group. At 20 years, LITA grafting of the LAD at reoperation resulted in an absolute mortality risk reduc-
tion of 6.0% and a hazard ratio of 0.85, with number needed to treat of 16 patients.
Conclusions LITA-to-LAD grafting at reoperation is safe and confers a risk-adjusted survival advantage. When appropriate, a LITA
should be used to revascularize the LAD at coronary reoperations. (J Am Coll Cardiol 2013;61:302–10)
© 2013 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.09.045LLeft internal thoracic artery grafting (LITA) of the left
anterior descending coronary artery (LAD) at primary
coronary artery bypass grafting (CABG) prolongs long-
term survival and reduces late myocardial infarction, hospi-
talization for cardiac events, need for reoperation, and
return of angina (1,2). Whether there is a benefit of LITA
grafting of the LAD at reoperative CABG is unknown. To
determine if LITA grafting of the LAD at reoperative
CABG is associated with improved outcomes, we compared
hospital morbidity and mortality and long-term survival of
reoperative CABG patients who had either LITA or saphe-
nous vein (SV) grafting of the LAD.
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2012, accepted September 11, 2012.Methods
From January 1985 to January 2007, isolated reoperative
CABG was performed at Cleveland Clinic on 4,087 pa-
tients who did not have their LITA used as a bypass graft at
their primary operation and who had anterior wall myocar-
dium at risk (50% stenosis of the LAD, previous LAD
bypass graft, or both). Of these, 3,473 patients had either
the LITA (n 2,389) or SV (n 1,084) used to bypass the
AD coronary artery system.
See page 311
We excluded 614 patients for the following reasons: 1) 82
patients had no SV or LITA used to bypass the LAD; 2)
159 patients had LITA grafts used to bypass the diagonal
and SVs to bypass the LAD; 3) 11 patients had a LITA to
diagonal, and SV to both the LAD and diagonal; 4) 68
patients had both LITA and SVs to the LAD; 5) 17
patients had LITA to the LAD and SV to both the LAD
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diagonal, and SV to the LAD; 6) 5 patients had a radial artery
used to bypass the LAD, and SV to LAD or diagonal; 7) 54
patients had reoperative surgery prior to 1973, when LITA
grafts were not used; and 8) 214 patients had prior Vineberg
operations (tunneling the LITA into the myocardium).
Of the 3,473 patients, 1,909 (55%) had their primary
CABG performed outside Cleveland Clinic. Most of these
patients had their primary CABG performed before 1990
(Online Fig. 1A), prior to increasing use of internal thoracic
artery (ITA) grafting. Nevertheless, 1,819 patients (52%) had
their primary surgery outside Cleveland Clinic after January 1,
1980. Of the 1,564 patients who had their primary CABG
performed at Cleveland Clinic, most also had that surgery
before 1985 (Online Fig. 1B). A substantial number of patients
in the study—271 of 1,477 patients for whom catheterization
data were available before primary CABG (18%)—had non-
significant LAD disease at the time of their primary operation.
Variables and definitions. Patient characteristics, opera-
tive techniques, and hospital outcomes were obtained by
routine prospective data collection during hospital admis-
sion for reoperative CABG and stored in the Cardiovascular
Information Registry (CVIR). Left ventricular function was
echocardiographically graded as normal (ejection fraction
[EF] 60%), mild dysfunction (EF 40% to 59%), moderate
dysfunction (EF 25% to 39%), or severe dysfunction (EF
25%). A coronary artery system was considered impor-
tantly stenotic if it contained a 50% diameter obstruction.
Incomplete revascularization was defined as failure to graft
any system containing 50% stenosis, or both LAD and
circumflex coronary systems for 50% left main trunk
stenosis. The Cleveland Clinic Institutional Review Board
approved use of these data for clinical research.
Endpoints. The primary endpoint of the study was long-
erm mortality. Late death was obtained from routine
nniversary follow-up in the CVIR. Follow-up was contin-
ed to 20 years post-operatively. This active follow-up was
upplemented with data from the Social Security Death
aster File, set back to a common closing date of Decem-
er 1, 2010 (3,4), and accessed on April 1, 2011. Mean
ollow-up was 11 8.2 years (median 14 years), and 10% of
patients were followed more than 22 years. A total of 37,638
patient-years of follow-up data were available for analysis.
The secondary endpoint was post-operative hospital
outcomes, with morbidities defined as for the Society of
Thoracic Surgeons National Database (5).
Statistical analysis. PRE-OPERATIVE GROUP DIFFERENCES. To
identify differences in characteristics of patients receiving
either the LITA or SVs to graft the LAD at reoperative
CABG, those associated with grafting the LAD with the
SV were identified by multivariable logistic regression anal-
ysis. These variables included interval from primary surgery
as well as surgeon. Variables were selected (Online Appen-
dix) using bootstrap aggregation (bagging), with automated
analysis of 500 resampled datasets and a criterion of p 0.05 for variable retention (6).
Factors appearing in 50% of
the models (median rule) were
retained to create a parsimonious
model.
PRIMARY ENDPOINT: TIME-
RELATED MORTALITY. Survival
fter CABG was estimated non-
arametrically using the Kaplan-
eier method (7) and paramet-
ically using multiphase hazard
ethodology (8). The latter in-
olved identifying the number of
azard phases, appropriate form
f equation for each phase, and
arameters characterizing distribution of times to death (9).
ADJUSTED SURVIVAL AND SECONDARY ENDPOINTS. Be-
cause selection bias may have influenced outcomes, we used 2
methods to adjust for differences in patients having either an
SV or LITA graft to the LAD: propensity matching (10) and
multivariable analysis that incorporated a propensity score (11).
The parsimonious logistic regression model just described was
augmented into a semisaturated propensity model by including
patient characteristics that were not statistically significantly
different between groups, but represented demographic, car-
diac, and noncardiac comorbidities (these are identified in the
Online Appendix) (12,13). The C-statistic for this model was
0.76. A propensity score was then calculated for each patient
and used to identify 908 matched pairs (84% of possible
matches). Distribution of propensity scores for LITA and SV
groups was such that patients highly likely to receive a LITA
graft and those highly likely to receive a SV graft were not
matched, but rather matching took place over a wide range of
intermediate propensity scores from about 10% to about 70%
(Online Fig. 2). Standardized differences showed that covariate
balance was achieved across the majority of variables (Online
Fig. 3) (14). Outcomes of these matched pairs were compared.
Continuous variables were compared using the Wilcoxon rank
sum test and categorical variables using the chi-square test.
Survival curves were tested overall by the log-rank test, but
specifically for early and late risk by forcing into both hazard
phases the indicator variable for LITA versus SV grafting and
the propensity score.
Second, multivariable analysis in the hazard function
domain was performed to identify factors simultaneously
associated with early and late survival. This analysis permit-
ted assessment of single LITA grafting to the LAD and use
of bilateral ITA grafting with at least 1 graft to the LAD.
Bootstrap aggregation of 500 models was used for variable
selection (Online Appendix) with LITA versus SV use
forced into the model. Variables appearing in 50% of
models with p  0.05 were retained. Propensity for SV was
permitted to enter the models, but was also forced into final
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
CVIR  Cardiovascular
Information Registry
EF  ejection fraction
ITA  internal thoracic
artery
LAD  left anterior
descending coronary artery
LITA  left internal
thoracic artery
SV  saphenous veinmodels for maximum risk adjustment.
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LITA-to-LAD Grafting at Coronary Reoperation January 22, 2013:302–10Patient Characteristics Stratified by LITA or SV Graft to LAD GroupTable 1 Patient Characteristics Stratified by LITA or SV Graft to LAD Group
Characteristic n* LITA Graft (n  2,389) n* SV Graft (n  1,084) p Value
Demography
Age, yrs 2,389 62 9.3 1,084 65 9.4 0.0001
Male 2,389 2,077 (87) 1,084 887 (82) 0.0001
Pre-operative NYHA
functional class
2,389 1,084 0.09
I 292 (12) 137 (13)
II 803 (34) 318 (29)
III 267 (11) 134 (12)
IV 1,027 (43) 495 (46)
Cardiac comorbidity
Emergency status 2,382 32 (1.3) 1,079 47 (4.4) 0.0001
Previous MI 2,389 1,669 (70) 1,084 787 (73) 0.1
Heart failure 2,389 266 (11) 1,084 162 (15) 0.002
Number of CAD
systems with
stenosis 50%
2,375 1,075 0.06
Isolated LM 50% 6 (0.25) 7 (0.65)
1 80 (3.4) 22 (2.0)
2 400 (17) 180 (17)
3 1,889 (80) 866 (81)
Atrial fibrillation 2,389 34 (1.4) 1,084 31 (2.9) 0.004
Noncardiac comorbidity
Smoking 2,333 1,516 (65) 1,062 680 (64) 0.6
Hypertension 1,829 1,196 (65) 828 551 (67) 0.6
Treated diabetes 2,199 383 (17) 985 190 (19) 0.2
Stroke 2,389 121 (5.1) 1,084 89 (8.2) 0.0003
Peripheral arterial
disease
2,389 365 (15) 1,084 183 (17) 0.2
Pre-operative creatinine,
mg●dl1
975 1.2 0.8 537 1.4 0.9 0.0001
Pre-operative cholesterol,
mg●dl1
1,251 221 58 500 224 56 0.3
Pre-operative triglycerides,
mg●dl1
1,080 202 169 447 192 141 0.5
Primary CABG details
Graft locations
LAD system 2,287 1,863 (81) 1,005 882 (88) 0.0001
Cx system 2,287 1,532 (67) 1,005 622 (62) 0.005
RCA system 2,287 1,527 (67) 1,005 616 (61) 0.002
Reoperative CABG
details
Graft locations
LAD system 2,389 2,389 (100) 1,084 1,084 (100)
Cx system 2,389 1,784 (75) 1,084 815 (75) 0.8
RCA system 2,389 1,569 (66) 1,084 628 (61) 0.004
ITA grafting
Single 2,389 1,972 (83) 1,084 183 (17) 0.0001
Bilateral 2,389 417 (17) 1,084 11 (1.0) 0.0001
Complete
revascularization
2,389 1,727 (72) 1,084 734 (68) 0.006
Values are mean  SD or n (%). *Patients with data available.
CABG  coronary artery bypass grafting; Cx  circumflex coronary artery system; ITA  internal thoracic artery; LAD  left anterior descendingcoronary artery; LITA left internal thoracic artery; LM left main coronary artery; MImyocardial infarction; NYHA New York Heart Association;
RCA  right coronary artery system; SD  standard deviation; SV  saphenous vein.
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quencies and percentages and continuous variables by means
and standard deviations. Asymmetric confidence limits of
nonparametric survival estimates and confidence bands
around parametric estimates are equivalent to 1 standard
error (68%). Difference in survival across time (absolute risk
reduction) is expressed as the inverse of this difference,
termed number needed to treat, accompanied by 68% confi-
dence bands for the difference (15).
Results
Pre-operative group differences. Many pre-operative and
operative characteristics of patients with the LAD grafted at
reoperative CABG with either the LITA or SV were similar
(Table 1); however, patients who received an SV were older
and more likely to have previous stroke, lower EF, more left
main stenosis, emergency operation, earlier date of opera-
tion, the LAD grafted at prior CABG, and occlusion of the
LAD. Patients having LITA-to-LAD grafting were more
likely to have single-system coronary artery disease, greater
diagonal stenosis, and more distal anastomoses at primary
operation (Table 2).
Primary endpoint. UNADJUSTED SURVIVAL. Overall unad-
usted survival estimates at 6 months and 1, 5, 10, 15, and
0 years were 94%, 92%, 80%, 59%, 41%, and 27%,
espectively. A 2-phase hazard model was identified, con-
isting of a small early phase lasting about 6 months and
ccounting for 200 of the overall 2,302 deaths, and a late
eclining phase thereafter.
Unadjusted survival was significantly higher in patients
aving their LAD grafted by the LITA versus the SV.
nadjusted survival estimates at 6 months and 1, 5, 10, 15,
nd 20 years for these patients were 95%, 94%, 82%, 64%,
6%, and 32%, respectively. In contrast, for those receiving
n SV, unadjusted survival estimates were 90%, 88%, 73%,
0%, 32%, and 18%, respectively (p  0.0001). Separation
f survival curves occurred early after operation (Fig. 1A),
onfirmed by a substantially higher instantaneous risk of
eath (hazard function) immediately after operation
Fig. 1B). Late risk diverged as long as patients were
ollowed.
ADJUSTED SURVIVAL. Propensity matching. After propensity
atching, both early (p  0.01) and long-term risk (p 
.005) were significantly lower for patients undergoing
ITA grafting of the LAD rather than SV grafting at
eoperative CABG. In the matched pairs, this resulted in
-month and 1-, 5-, 10-, 15-, and 20-year propensity-
djusted survival estimates for patients having a LITA-to-
AD graft of 94%, 93%, 79%, 58%, 40%, and 25%,
espectively, versus 91%, 89%, 74%, 52%, 33%, and 19%,
espectively, for those having an SV-to-LAD graft. As in
he unadjusted analysis, the survival curves separated early
fter operation and remained separated out to 20 years
Fig. 2A), the latter reflecting an initial higher instantaneous
isk of death early after SV grafting that rapidly fell to a nadir sbout 6 months after operation, before slowly rising (Fig. 2B).
hroughout time, risk of death remained higher after SV
rafting and continued to diverge from that for LITA-to-
AD grafting for at least 20 years. Difference in percent
urvival was maximum at 12 years (Fig. 2C). At 20 years,
bsolute risk reduction was 6.0%, the hazard ratio was 0.85,
nd the number needed to treat was 16 patients (Fig. 2D).
he survival advantage of LITA-to-LAD grafting at reop-
rative CABG versus SV-to-LAD was consistent across
atient age at reoperation, with convergence of survival
urves only as they eventually approached zero (Fig. 2E).
ultivariable Adjustment. After adjustment for multiple
isk factors as well as propensity score, single ITA grafting
o the LAD was associated with statistically significantly
ower early risk; however, magnitude of single ITA and
ilateral ITA grafting was equivalent (Table 3). In the late
azard phase, both single and bilateral ITA grafting were
ssociated with lower risk, but the latter with substantially
ore effect.
econdary endpoints. Unadjusted hospital outcomes were
Factors Related to Graft Choice forLAD Revascularization at Reop rationTable 2 F ctors Related to Graft Choice forLAD Revascularization at Reoperation
Factor Estimate  SE p Value Reliability (%)*
Factors associated with
LITA graft use
Cardiac comorbidity
Greater diagonal
stenosis
0.39 0.101 0.0001 64
Single-system CAD 0.78 0.259 0.003 64
Characteristics of
prior CABG
Previous distal
number
0.18 0.041 0.0001 68
Diagonal graft 0.39 0.101 0.0001 83
Factors associated with
SV graft use
Demography
Older age 0.68 0.065 0.0001 98
Female 0.30 0.106 0.004 50
Cardiac comorbidity
LV dysfunction† 0.105 0.038 0.006 86
Left main trunk
stenosis
0.36 0.122 0.003 58
Cx stenosis 0.003 0.001 0.005 50
LAD occlusion 0.42 0.088 0.0001 58
Prior CABG
Prior LAD
grafting
0.46 0.116 0.0001 50
Emergency
operation
1.08 0.242 0.0001 91
Earlier date of
operation
0.59 0.081 0.0001 88
Noncardiac
comorbidity
Previous stroke 0.47 0.152 0.002 78
Intercept  2.19  0.261. *Percent of times factor appeared in 500 bootstrap analyses.
Ordinal variable (none, mild, moderate, severe dysfunction).
CAD  coronary artery disease; LV  left ventricular; other abbreviations as in Table 1.ignificantly better in patients having the LAD grafted with
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propensity-matched pairs, hospital mortality, stroke, and
respiratory failure were significantly lower in the LITA
group; all other hospital outcomes were similar (Table 4).
Discussion
Background. LITA grafting of the LAD is undoubtedly
the most important component of primary surgical revascu-
larization. When used to graft the LAD at primary CABG,
LITA grafting is superior to SV grafting in prolonging
survival and decreasing recurrent angina, myocardial infarc-
tion, hospitalization for ischemic events, and coronary
reintervention (1,2). These benefits of LITA grafts are due
Figure 1
Unadjusted Mortality After Reoperative CABG
Stratified by Left Internal Thoracic Artery
or SV Grafting of LAD Coronary Artery
(A) Survival. Symbols at 1, 5, 10, 15, and 20 years are Kaplan-Meier esti-
mates accompanied by vertical bars representing asymmetric confidence limits
equivalent to 1 standard error. Numbers in parentheses are number of
patients remaining at risk at these intervals. Solid lines within dashed confi-
dence bands represent parametric estimates. (B) Hazard functions. Parametric
point estimates are accompanied by confidence bands as in A. Red  left
internal thoracic artery grafting; blue  saphenous vein (SV) grafting. CABG 
coronary artery bypass grafting; LAD  left anterior descending coronary artery.to their superior patency over SV grafts (16).LITA grafting of the LAD may have similar benefits for
reoperative CABG patients with anterior wall ischemia.
Although this may seem logical, there are reasons why it
may not be so, and to our knowledge, no previous study has
investigated whether LITA-to-LAD grafting offers clinical
advantages at reoperative CABG. First, reoperative CABG
patients are older and have more risk factors than primary
CABG patients (17). Any survival benefit or improve-
ment in freedom from recurrent ischemic events from
LITA grafting may not be realized because of the
expected shorter remaining life of reoperative CABG
patients. Second, reoperative CABG carries more risk
than primary CABG, and any clinical benefit of LITA
grafting after reoperation may be negated by more
complications and greater mortality (17–25). Therefore,
we sought to assess whether LITA grafting to the LAD
at reoperative CABG resulted in better patient outcomes
than SV grafting. Although most of the patients in this
study had their primary CABG prior to 1986 (after which
ITA grafting at primary CABG became preferred), this
study is still applicable today. Many patients in this study
had their primary CABG after 1986 without ITA graft-
ing of the LAD. Further evidence that a substantial
proportion of primary CABG patients today are not
receiving an ITA graft comes from the STS database. In
2011, nearly 5% of patients undergoing primary CABG
did not receive an ITA graft. This translates into approx-
imately 10,000 patients per year in the United States
alone without ITA grafting at their primary operation.
Principal findings. LITA grafting of the LAD at reopera-
tive CABG was associated with better early and late survival
than was SV grafting. It also was associated with decreased
hospital mortality and respiratory failure. Most hospital
morbidities, however, were similar.
The results of CABG are directly related to graft patency
(26), and the better early and late survival observed in
reoperative CABG patients with LITA-to-LAD grafts are
likely related to superior early and late patency of LITA
grafts. At 1 and 10 years after CABG, more than 90% of
ITA grafts are patent (16,26–29). This excellent and stable
patency is due to ITAs’ resistance to arteriosclerosis. Less
than 4% of ITAs develop arteriosclerosis, and only 1%
develop important stenosis due to arteriosclerosis (30–32).
SV graft patency is not as robust and stable as LITA patency.
By 1 year after surgery, 10% to 20% of SV grafts are occluded,
a result of technical errors, thrombosis, and intimal hyperplasia
(16,26,33). From 1 to 5 years after surgery, 1% to 2% of SV
grafts occlude each year, and from 6 to 10 years, an additional
4% to 5% occlude annually (30). After 1 year, SV graft
occlusion is due to arteriosclerosis (30). By 10 years, only 50%
to 60% of SV grafts are patent, and only half of these are free
of angiographic arteriosclerosis (30).
Better early morbidity (fewer complications) observed in
the ITA group is also likely due to better early patency of
ITA versus SV grafts. Better patency would result in less
myocardial ischemia post-operatively, with better cardiac
307JACC Vol. 61, No. 3, 2013 Sabik et al.
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tions, such as respiratory failure, renal failure, and hypoten-
sion resulting in stroke.
Although it may seem best to always graft the LAD
Figure 2 Mortality Among Propensity-Matched Pairs of Patient
by Left Internal Thoracic Artery or Saphenous Vein Gr
(A) Survival. Format is as in Figure 1A. (B) Hazard functions. Format is as in Figur
enclosed within confidence limits equivalent to 1 standard error. (D) Absolute ris
dence limits equivalent to 1 standard error. (E) Five- and 15-year survival differe
range of ages.with a LITA at reoperative CABG, a word of caution isnecessary when using a LITA graft to replace a stenotic
but nonoccluded LAD SV graft. Navia and colleagues
demonstrated that in patients undergoing reoperative
CABG, myocardial hypoperfusion, resulting in infarction
r Reoperative Coronary Artery Bypass Grafting Stratified
of Left Anterior Descending Coronary Artery
(C) Absolute risk reduction, presented as survival difference across time
ction, presented as number needed to treat across time enclosed within confi-
tween internal thoracic artery (red) and saphenous vein (blue) groups across as Afte
afting
e 1B.
k redu
nce beor cardiogenic shock, may occur when ligating and
nary ar
apheno
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LITA-to-LAD Grafting at Coronary Reoperation January 22, 2013:302–10replacing a nonoccluded SV graft to the LAD with only
a LITA graft (31). Therefore, when a LITA is used to
replace a nonoccluded SV graft, it is best not to ligate the
stenotic SV graft but to leave it in place and anastomose
Incremental Risk Factors for DeathTable 3 Incremental Risk Factors for Death
Risk Factor
Early phase
Older age†
Emergency operation
Height‡
LV dysfunction moderate or severe
Stenosis
In proximal LCx 0
In mid-LCx 0
In RCA system (posterior descending
coronary artery)
0
In LAD system (major septal perforator) 0
ITA use
Single ITA 
Bilateral ITA 
Propensity for SV graft
Late phase
Older age
LV dysfunction moderate or severe
Creatinine††
Hematocrit 
Previous stroke
History of PAD
Hypertension
Smoking
Diabetes in younger age‡‡
Pre-operative AF
First surgery: LAD system grafted
Stenosis in RCA proximal 0
Procedural: SV to RCA (at reoperation) 
ITA use
Single ITA 
Bilateral ITA 
Propensity for SV graft
*Percent of times factor appeared in 500 bootstrap models. †Exp(age
§90% reliability with any variable in size cluster. 87% reliability with a
stenosis cluster. #88% reliability with any variable in LAD stenosis
††Log(creatinine), logarithmic transformation. ‡‡Interaction of treate
CABG  coronary artery bypass grafting; Cx  circumflex coronary
coronary artery; LITA left internal thoracic artery; LM left main coro
RCA  right coronary artery system; SD  standard deviation; SV  s
Hospital Outcomes After LITA or SV Grafting of the LAD at ReoperaTable 4 Hospital Outcomes After LITA or SV Grafting of the LA
Variable
Unadjusted
LITA Graft
(n  2,389)
SV Graft
(n  1,084)
Hospital death 53 (2.2) 71 (6.5)
Stroke 38 (1.6) 45 (4.1)
Return to OR for bleeding 90 (3.8) 62 (5.7)
Respiratory insufficiency 157 (6.6)* 136 (12)†
Renal failure 63 (2.6) 53 (4.9)Values are n (%). *n  2,385. †n  1,083. ‡n  907.
OR operating room; other abbreviations as in Table 1.the LITA distal to it. If the old LAD SV graft must be
ligated, it is best to either replace it with another SV graft
or graft the LAD with a LITA and place an SV graft to
a diagonal. Other reasons not to use an ITA graft at
te  SE p Value Reliability (%)*
 0.115 0.005 79
 0.264 0.0005 89
 1.37 0.0004 53§
 0.153 0.0008 78
 0.00175 0.02 62
 0.00198 0.02 52
 0.00372 0.04 50¶
 0.00343 0.03 60#
98
 0.173 0.002 40**
 0.323 0.16 40**
 0.367 0.0001 NA**
 0.046 .0001 100
 0.247 .0001 98
 0.109 .0001 93
 0.0078 0.003 64
 0.096 0.0001 96
 0.069 .0001 98
 0.056 0.007 81
 0.054 0.009 80
 0.094 .0001 81
 0.151 0.007 52
 0.061 0.01 68
 0.00053 .0001 98§§
 0.061 0.0008 80
100
 0.056 0.02 73**
 0.091 0.0002 73**
 0.127 0.5 NA**
xponential transformation. ‡Log(height), logarithmic transformation.
able in LCx stenosis cluster. ¶87% reliability with any variable in RCA
. **All 3 variables retained in each phase regardless of reliability.
tes and 1/(age)2. §§Reliability of any variable in RCA stenosis cluster.
ystem; ITA  internal thoracic artery; LAD  left anterior descending
tery; MImyocardial infarction; NYHA New York Heart Association;
us vein.
CABGReoperative CABG
Adjusted
p Value
LITA Graft
(n  908)
SV Graft
(n  908) p Value
0.0001 28 (3.1) 51 (5.6) 0.008
0.0001 14 (1.5) 38 (4.2) 0.0007
0.009 41 (4.5) 45 (4.9) 0.7
0.0006 76 (8.4)‡ 106 (12)‡ 0.019
0.0001 28 (3.1) 42 (4.6) 0.09Estima
0.32
0.91
4.7
0.50
.0042
.0047
.0075
.0074
0.54
0.46
1.4
0.75
0.46
0.64
0.023
0.33
0.34
0.17
0.14
0.87
0.41
0.16
.0022
0.16
0.127
0.34
0.084
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January 22, 2013:302–10 LITA-to-LAD Grafting at Coronary Reoperationreoperation include: 1) subclavian stenosis (32); 2) prior
ITA damage caused by radiation; 3) an arteriosclerotic
ITA; 4) prior ITA damage by sternal wires; and 5)
catastrophe on sternal reentry that prevents adequate
time for ITA harvesting.
Study limitations. This was an observational, comparative
ffectiveness, nonrandomized study, and patient selection
ay play a role in our findings. To adjust for this, we used
propensity score to identify similar groups of patients for
omparison of outcomes. Although the comparison groups
ere well matched, any patient factors not included in the
ropensity model that importantly affect outcomes might
ias our findings. No angiographic patency data are in-
luded in the present study, but have been reported (16).
lthough we hypothesize that the improved survival in the
TA group was due to better ITA patency, we do not have
ata to support this. However, multiple studies have previ-
usly demonstrated better early and late ITA over SV
atency, including our own study (16).
This was also a single-institution study, and results may
ot be generalizable. However, with decreasing risk of
ABG reoperations, and with widespread experience with
TA grafting these days, our experience should be repeat-
ble in other centers that continue to see patients from the
re-ITA era in need of reoperative CABG.
onclusions
oth early and long-term survival are better when the
ITA, as opposed to the SV, is used to graft the LAD at
eoperative CABG in patients with anterior wall ischemia.
ospital morbidity is similar when either the LITA or SV
s used to graft the LAD.
linical inferences. In patients undergoing reoperative
CABG with anterior wall ischemia, to improve long-
term survival, it is best, when appropriate, to use a LITA
to graft the LAD.
Acknowledgments
This study was supported in part by the Sheikh Hamdan bin
Rashid Al Maktoum Distinguished Chair in Thoracic and
Cardiovascular Surgery (held by Dr. Sabik) and the Ken-
neth Gee and Paula Shaw, PhD, Chair in Heart Research
(held by Dr. Blackstone).
Reprint requests and correspondence: Dr. Joseph F. Sabik III,
Department of Thoracic and Cardiovascular Surgery, Cleveland
Clinic, 9500 Euclid Avenue/Desk J4-1, Cleveland, Ohio 44195.
E-mail: sabikj@ccf.org.
REFERENCES
1. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-
mammary-artery graft on 10-year survival and other cardiac events.
N Engl J Med 1986;314:1–6.
2. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery
with internal-thoracic-artery grafts–effects on survival over a 15-year
period. N Engl J Med 1996;334:216–9.3. Boyle CA, Decoufle P. National sources of vital status information:
extent of coverage and possible selectivity in reporting. Am J Epide-
miol 1990;131:160–8.
4. Newman TB, Brown AN. Use of commercial record linkage software
and vital statistics to identify patient deaths. J Am Med Inform Assoc
1997;4:233–7.
5. Shahian DM, O’Brien SM. Filardo G, et al. The Society of Thoracic
Surgeons 2008 cardiac surgery risk models: part 1—coronary artery
bypass grafting surgery. Ann Thorac Surg 2009;88:S2–22.
6. Breiman L. Bagging predictors. Machine Learning 1996;24:123–40.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete
observations. J Am Stat Assoc 1958;53:457–81.
8. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of
time-varying hazard into phases, each incorporating a separate stream
of concomitant information. J Am Stat Assoc 1986;81:615–24.
9. Hazard function technology. Available at: http://my.clevelandclinic.org/
professionals/software/hazard/default.aspx. Accessed November 2012.
10. Rosenbaum PR, Rubin DB. The central role of the propensity score in
observational studies for causal effects. Biometrika 1983;70:41–55.
11. Drake C, Fisher L. Prognostic models and the propensity score. Int J
Epidemiol 1995;24:183–7.
12. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc
Surg 2002;123:8–15.
13. Rubin DB. The design versus the analysis of observational studies for
causal effects: parallels with the design of randomized trials. Stat Med
2007;26:20–36.
14. Austin PC. A comparison of propensity score methods: a case-study
estimating the effectiveness of post-MI statin use. Stat Med 2006;25:
2084–106.
15. Altman DG, Andersen PK. Calculating the number needed to treat
for trials where the outcome is time to an event. Brit Med J
1999;319:1492–5.
16. Sabik JF 3rd, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove
DM. Comparison of saphenous vein and internal thoracic artery graft
patency by coronary system. Ann Thorac Surg 2005;79:544–51.
17. Sabik JF 3rd, Blackstone EH, Houghtaling PL, Walts PA, Lytle BW.
Is reoperation still a risk factor in coronary artery bypass surgery? Ann
Thorac Surg 2005;80:1719–27.
18. Edwards FH, Clark RE, Schwartz M. Coronary artery bypass grafting:
the Society of Thoracic Surgeons National Database experience. Ann
Thorac Surg 1994;57:12–9.
19. Christenson JT, Simonet F, Schmuziger M. The impact of a short
interval (1 year) between primary and reoperative coronary artery
bypass grafting procedures. Cardiovasc Surg 1996;4:801–7.
20. He GW, Acuff TE, Ryan WH, He YH, Mack MJ. Determinants of
operative mortality in reoperative coronary artery bypass grafting.
J Thorac Cardiovasc Surg 1995;110:971–8.
21. Noyez L, van Eck FM. Long-term cardiac survival after reoperative
coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;25:59–64.
22. van Eck FM, Noyez L, Verheugt FW, Brouwer RM. Changing profile
of patients undergoing redo-coronary artery surgery. Eur J Cardiotho-
rac Surg 2002;21:205–11.
23. Yap CH, Sposato L, Akowuah E, et al. Contemporary results show
repeat coronary artery bypass grafting remains a risk factor for
operative mortality. Ann Thorac Surg 2009;87:1386–91.
24. Brooks N, Honey M, Cattell M, et al. Reoperation for recurrent
angina. Br Heart J 1979;42:333–8.
25. Di Mauro M, Iaco AL, Contini M, et al. Reoperative coronary
artery bypass grafting: analysis of early and late outcomes. Ann
Thorac Surg 2005;79:81–7.
26. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton
JR. Coronary bypass graft fate and patient outcome: angiographic
follow-up of 5,065 grafts related to survival and reoperation in 1,388
patients during 25 years. J Am Coll Cardiol 1996;28:616–26.
27. Grondin CM, Campeau L, Lesperance J, Enjalbert M, Bourassa MG.
Comparison of late changes in internal mammary artery and saphenous
vein grafts in two consecutive series of patients 10 years after operation.
Circulation 1984;70:208–12.
28. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC.
Long-term (5 to 12 years) serial studies of internal mammary artery
and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg
1985;89:248–58.
29. Bjork VO, Ivert T, Landou C. Angiographic changes in internal
mammary artery and saphenous vein grafts, two weeks, one year and
33
3
3
310 Sabik et al. JACC Vol. 61, No. 3, 2013
LITA-to-LAD Grafting at Coronary Reoperation January 22, 2013:302–10five years after coronary bypass surgery. Scand J Thorac Cardiovasc
Surg 1981;15:23–30.
0. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M,
Lesperance J. Long-term fate of bypass grafts: the Coronary Artery
Surgery Study (CASS) and Montreal Heart Institute experiences.
Circulation 1985;72:V71–8.
1. Navia D, Cosgrove DM 3rd, Lytle BW, et al. Is the internal thoracic
artery the conduit of choice to replace a stenotic vein graft? Ann
Thorac Surg 1994;57:40–3, discussion 3–4.
2. Liava’a M, Theodore S, Brown R, Luthra S, Tatoulis J. Progressive
subclavian artery stenosis causing late coronary artery bypass graft
failure as a result of coronary-subclavian artery steal. J Thorac
Cardiovasc Surg 2008;135:438–9.3. Chesebro JH, Fuster V, Elveback LR, et al. Effect of dipyridamole and
aspirin on late vein-graft patency after coronary bypass operations.
N Engl J Med 1984;310:209–14.
Key Words: coronary disease y internal thoracic artery y reoperation y
revascularization y surgery y survival.
APPENDIX
For an expanded Methods section and supplemental figures,
please see the online version of this article.
